valvular atrial fibrillation
Conditions
Interventions
Experiment group:rivaroxaban
Control group:warfarin or other treatment
Sponsors
The Second Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age = 18 years; 2.Female patients had to be either postmenopausal, surgically sterile, abstinent, or using appropriate birth control before entry and throughout the study, and negative for pregnancy test using serum ß-human chorionic gonadotropin at screening; 3.The diagnosis of valvular AF was based on history, electrocardiogram, ambulatory electrocardiographic monitoring, and clinical findings.
Exclusion criteria
Exclusion criteria: 1. Have a history of heart related diseases (mitral stenosis with significant hemodynamics, artificial heart valves, known presence of cardiac myxoma or left ventricular mural thrombus or active endocarditis); 2. Have a history of serious lung, liver, kidney or nervous system disease or mental disease; 3. The daily dose of aspirin exceeds 165 mg, or aspirin and clopidogrel are taken at the same time; 4. The expected life is less than 1 year; 5. Current alcoholism, drug abuse or psychosocial problems.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| systemic embolism;stroke;Blooding; | — |
Secondary
| Measure | Time frame |
|---|---|
| the quality of life;adverse events; | — |
Countries
China
Contacts
Public ContactBin Wang
The Second Hospital of Hebei Medical University
Outcome results
None listed